Good Life Advisors’s Medtronic MDT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $211K | Sell |
2,417
-1,508
| -38% | -$128K | 0.01% | 474 |
|
|
2025
Q1 | $353K | Buy |
3,925
+1,016
| +35% | +$90.9K | 0.02% | 357 |
|
|
2024
Q4 | $232K | Sell |
2,909
-961
| -25% | -$83.2K | 0.02% | 419 |
|
|
2024
Q3 | $348K | Buy |
3,870
+276
| +8% | +$23.2K | 0.02% | 428 |
|
|
2024
Q2 | $283K | Sell |
3,594
-17
| -0.5% | -$1.39K | 0.02% | 373 |
|
|
2024
Q1 | $315K | Buy |
3,611
+934
| +35% | +$79.7K | 0.03% | 338 |
|
|
2023
Q4 | $221K | Sell |
2,677
-415
| -13% | -$31.6K | 0.02% | 394 |
|
|
2023
Q3 | $242K | Buy |
3,092
+7
| +0.2% | +$586 | 0.03% | 353 |
|
|
2023
Q2 | $272K | Sell |
3,085
-125
| -4% | -$10.8K | 0.03% | 326 |
|
|
2023
Q1 | $259K | Buy |
3,210
+223
| +7% | +$18.2K | 0.03% | 320 |
|
|
2022
Q4 | $232K | Sell |
2,987
-344
| -10% | -$27.9K | 0.03% | 307 |
|
|
2022
Q3 | $269K | Sell |
3,331
-10,493
| -76% | -$943K | 0.04% | 268 |
|
|
2022
Q2 | $1.24M | Buy |
13,824
+144
| +1% | +$14.6K | 0.17% | 112 |
|
|
2022
Q1 | $1.52M | Buy |
13,680
+81
| +0.6% | +$8.56K | 0.19% | 100 |
|
|
2021
Q4 | $1.41M | Sell |
13,599
-1,342
| -9% | -$155K | 0.17% | 103 |
|
|
2021
Q3 | $1.87M | Buy |
14,941
+1,927
| +15% | +$249K | 0.26% | 80 |
|
|
2021
Q2 | $1.61M | Buy |
13,014
+428
| +3% | +$53.7K | 0.31% | 61 |
|
|
2021
Q1 | $1.49M | Buy |
12,586
+364
| +3% | +$42.7K | 0.3% | 66 |
|
|
2020
Q4 | $1.43M | Buy |
12,222
+7
| +0.1% | +$771 | 0.34% | 59 |
|
|
2020
Q3 | $1.27M | Sell |
12,215
-311
| -2% | -$31.2K | 0.35% | 59 |
|
|
2020
Q2 | $1.15M | Buy |
12,526
+58
| +0.5% | +$5.56K | 0.34% | 65 |
|
|
2020
Q1 | $1.13M | Sell |
12,468
-128
| -1% | -$13.6K | 0.41% | 59 |
|
|
2019
Q4 | $1.43M | Buy |
12,596
+81
| +0.6% | +$8.89K | 0.41% | 49 |
|
|
2019
Q3 | $1.35M | Buy |
12,515
+29
| +0.2% | +$3.03K | 0.42% | 50 |
|
|
2019
Q2 | $1.22M | Buy |
12,486
+13
| +0.1% | +$1.19K | 0.35% | 53 |
|
|
2019
Q1 | $1.13M | Sell |
12,473
-36
| -0.3% | -$3.22K | 0.34% | 53 |
|
|
2018
Q4 | $1.14M | Buy |
12,509
+4,146
| +50% | +$387K | 0.37% | 53 |
|
|
2018
Q3 | $827K | Buy |
8,363
+95
| +1% | +$8.78K | 0.24% | 74 |
|
|
2018
Q2 | $707K | Buy |
8,268
+399
| +5% | +$33.3K | 0.23% | 83 |
|
|
2018
Q1 | $610K | Buy |
7,869
+219
| +3% | +$18.1K | 0.21% | 85 |
|
|
2017
Q4 | $654K | Buy |
7,650
+62
| +0.8% | +$4.96K | 0.2% | 78 |
|
|
2017
Q3 | $586K | Buy |
7,588
+147
| +2% | +$12.2K | 0.22% | 75 |
|
|
2017
Q2 | $650K | Buy |
7,441
+169
| +2% | +$14.3K | 0.28% | 64 |
|
|
2017
Q1 | $584K | Buy |
7,272
+855
| +13% | +$66.8K | 0.28% | 67 |
|
|
2016
Q4 | $470K | Buy |
+6,417
| New | +$504K | 0.27% | 65 |
|
Other funds holding MDT
Good Life Advisors's MDT Position: Q2 2025 in Review
Good Life Advisors reduced its Medtronic (MDT) stake by 38% in Q2 2025, selling an estimated $128K and leaving 2,417 shares worth $211K. The position accounts for 0.01% of the portfolio, ranked #474.
Good Life Advisors first reported a position in MDT in Q4 2016 and has held it in 35 quarters since. The position peaked at $1.87M in Q3 2021. 2,139 funds tracked by Wall St. Rank hold MDT as of Q2 2025.
- Good Life Advisors held 2,417 shares of Medtronic worth $211K as of Q2 2025.
- Good Life Advisors sold 1,508 Medtronic shares in Q2 2025, an estimated $128K.
- Medtronic made up 0.01% of Good Life Advisors's portfolio in Q2 2025, its #474 holding.
- Good Life Advisors first reported a position in Medtronic in Q4 2016 and has held it in 35 quarters since.
- Good Life Advisors's Medtronic position peaked at $1.87M in Q3 2021.
- 2,139 funds tracked by Wall St. Rank held Medtronic as of Q2 2025.
Based on Good Life Advisors's 13F filing for Q2 2025, filed 8 Aug 2025.